Intellia Therapeutics Inc... (NTLA)
7.32
0.67 (9.99%)
At close: Apr 02, 2025, 3:59 PM
6.68
-8.68%
After-hours: Apr 02, 2025, 07:59 PM EDT
Intellia Therapeutics Balance Sheet Statement
Financials in USD. Fiscal year
is
January - December.
| Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 |
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 |
| Cash & Equivalents | 189.18M | 226.75M | 523.51M | 123.41M | 160.02M | 57.23M | 58.86M | 340.68M | 273.06M | 75.82M | 9.85M |
| Short-Term Investments | 412.33M | 685.48M | 669.12M | 625.28M | 437.35M | 222.5M | 255.2M | n/a | n/a | n/a | n/a |
| Long-Term Investments | 44.26M | 154.51M | 142.32M | 425.05M | 1.9M | 4.75M | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Assets | 260.21M | n/a | n/a | n/a | 21.99M | 2.92M | 5.28M | 6.13M | 7.04M | 1.8M | 256K |
| Receivables | 8.52M | 36.46M | 3.77M | 2.03M | 2.13M | 4.62M | 7.55M | 10.47M | 6.45M | 1M | n/a |
| Inventory | n/a | n/a | -69.34M | -337.36M | -19.15M | 1.00 | 1.00 | 1.00 | 1.00 | n/a | n/a |
| Other Current Assets | 29.83M | 49.65M | 20.41M | 18.58M | n/a | 5.13M | 3.37M | 3.68M | 1.79M | n/a | n/a |
| Total Current Assets | 639.86M | 998.33M | 1.22B | 769.3M | 597.37M | 289.48M | 324.98M | 354.83M | 281.31M | 77.63M | 10.13M |
| Property-Plant & Equipment | 246.67M | 148.13M | 161M | 100.11M | 55.06M | 37.13M | 17.06M | 15.27M | 10.63M | 2.71M | 308K |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 551.15M | 302.65M | 303.32M | 525.16M | 78.95M | 44.8M | 22.34M | 21.41M | 17.66M | 4.51M | 564K |
| Total Assets | 1.19B | 1.3B | 1.52B | 1.29B | 676.32M | 334.28M | 347.31M | 376.24M | 298.97M | 82.14M | 10.69M |
| Account Payables | 14.59M | 7.45M | 5.15M | 9.65M | 10.46M | 3.94M | 2.71M | 2.17M | 4.65M | 1.36M | 199K |
| Deferred Revenue | 20.66M | 22.14M | 43.84M | 63.76M | 22.54M | 12.67M | 27.12M | 21.19M | 20.18M | 6.55M | n/a |
| Short-Term Debt | 20.25M | 13.79M | n/a | 9.11M | 5.7M | 5.75M | n/a | n/a | n/a | n/a | n/a |
| Other Current Liabilities | 55.35M | 40.4M | 39.1M | 13.84M | 8.94M | 1.22M | 4.57M | 3.23M | 3.2M | 1.51M | n/a |
| Total Current Liabilities | 110.85M | 115.21M | 126.55M | 125.83M | 64.25M | 35.63M | 40.57M | 31.36M | 30.73M | 10.7M | 2.35M |
| Long-Term Debt | 189.95M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Liabilities | 18.26M | n/a | 24.03M | n/a | n/a | n/a | 13K | 168K | 293K | 323K | 773K |
| Total Long-Term Liabilities | 208.21M | 135.6M | 157.98M | 128.39M | 85M | 28.77M | 28.82M | 44.28M | 58.4M | 4.09M | 773K |
| Total Liabilities | 319.06M | 250.81M | 284.53M | 254.22M | 149.25M | 64.4M | 69.39M | 75.64M | 89.13M | 14.78M | 3.13M |
| Total Debt | 210.2M | 115.35M | 130.7M | 74.02M | 39.3M | 18.38M | n/a | n/a | n/a | n/a | n/a |
| Common Stock | 10K | 9K | 9K | 7K | 7K | 5K | 5K | 4K | 4K | 3K | 657K |
| Retained Earnings | -2.18B | -1.66B | -1.18B | -703M | -435.11M | -300.88M | -201.03M | -121.11M | -53.57M | -21.94M | -9.54M |
| Comprehensive Income | 605K | -2.26M | -7.46M | -2.63M | 1K | 261K | -28K | -0.00 | -0.00 | -88.56M | -16.45M |
| Shareholders Equity | 871.96M | 1.05B | 1.24B | 1.04B | 527.07M | 269.88M | 277.92M | 300.6M | 209.84M | 67.36M | 7.57M |
| Total Investments | 456.6M | 839.99M | 811.44M | 1.05B | 437.35M | 227.25M | 255.2M | n/a | n/a | n/a | n/a |